ArticleJournal of gastrointestinal oncology2022

PRRX1 promotes colorectal cancer stemness and chemoresistance via the JAK2/STAT3 axis by targeting IL-6.

Longzhu Zhong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.